期刊文献+

结直肠腺瘤患者血清IGF-1和IGFBP-3的变化及其临床意义 被引量:7

Clinical significance of serum levels of IGF-1 and IGFBP-3 in patients with colorectal adenoma
下载PDF
导出
摘要 目的:研究血清胰岛素样生长因子1(insulin-like growth factor1,IGF-1)和胰岛素样生长因子结合蛋白3(insulin-like growth factor binding protein3,IGFBP-3)在结直肠腺瘤患者中的变化及临床意义.方法:采用放射免疫法和免疫放射法分别检测120例结直肠腺瘤患者、48例结直肠癌患者及34例健康人外周血清IGF-1和IGFBP-3表达水平.结果:血清IGF-1和IGF-1/IGFBP-3比值在结直肠癌组(247.35±60.77;0.063±0.010)、腺瘤性息肉组(224.75±69.45;0.055±0.010)及健康对照组(195.39±63.37;0.047±0.013)依次降低,前两组明显高于后组,差异有统计学意义(P<0.05).腺瘤性息肉患者血清IGF-1、IGFBP-3水平及IGF-1/IGFBP-3比值与患者的性别、年龄、吸烟饮酒情况及肿瘤家族史临床指标间均无统计学意义;与息肉大小、数量、部位、组织学分类也无统计学意义.血清IGF-1和IGF1/IGFBP-3比值在结直肠癌组(247.35±60.77;0.063±0.010)、进展期腺瘤组(235.81±73.72;0.056±0.011)及早期腺瘤组(208.15±59.44;0.052±0.008)依次降低,且前两组较后组比,差异有显著性(P<0.05).结直肠腺瘤性息肉患者血清IGF-1和IGFBP-3呈正相关(r=0.796,P<0.001).结论:血清IGF-1和IGF-1/IGFBP-3比值增高可能在结直肠腺瘤癌变中起一定作用,对适龄人群行血清GF-1和IGF-1/IGFBP-3检测可以简单筛选有息肉恶变倾向者. AIM:To investigate the clinical significance of serum levels of IGF-1 and IGFBP-3 in patients with colorectal adenoma. METHODS:Blood samples collected from 120 patients with colorectal adenoma (CRA), 48 patients with colorectal cancer (CRC) and 34 healthy controls were used to determine serum levels of IGF-l and IGFBP-3 by radioimmunoassay (RIA) and immunoradiometric assay (IRMA), respectively.RESULTS:Serum levels of IGF-1 and IGF-1/ IGFBP-3 ratio in the CRC group (247.35 ± 60.77; 0.063 ± 0.010) and CRA group (224.75 ± 69.45; 0.055 ± 0.010) were significantly higher than those in the healthy control group (195.39 ± 63.37; 0.047 ± 0.013) (both P 〈0.05). Serum IGF-1, IGFBP-3, and IGF-1/IGFBP-3 ratio in CRA showed no significant association with gender, age, history of smoking and drinking, family history of cancer, and the size, number, site or histological classification of polyps. Serum levels of IGF-1 and IGF-1/IGFBP-3 ratio in the CRC group (247.35 ± 60.77; 0.063 ± 0.010) and highrisk CRA group (235.81 ± 73.72; 0.056 ± 0.011) were significantly higher than those in the advanced CRA group (208.15 ± 59.44; 0.052 ± 0.008) (all P 〈0.05). There was a positive correlation between serum levels of IGF-1 and IGFBP-3 in CRA (r = 0.796, P 〈0.001). CONCLUSION:High serum levels of IGF-1 and IGF-1/ IGFBP-3 may play a role in the malignant transformation of colorectal adenoma, and detection of them can be used to screen precancerous lesions.
出处 《世界华人消化杂志》 CAS 北大核心 2012年第26期2529-2533,共5页 World Chinese Journal of Digestology
基金 青岛市科技局基金资助项目 No.10-3-3-4-6-nsh~~
关键词 结直肠腺瘤 胰岛素样生长因子1 胰岛素样生长因子结合蛋白3 放射免疫 免疫放射 Colorectal adenoma Insulin-like growth factor 1 Insulin-like growth factor binding protein 3 Radioimmunoassay Immunoradiometric assay
  • 相关文献

参考文献3

二级参考文献45

共引文献130

同被引文献120

  • 1何晶晶,黄甜,刘丽,向浩,刘莉,许奕华,魏晟,张肖肖,陈继贵,王倩,刘畅,聂绍发.结直肠癌组织IGF-ⅠR和IGF-Ⅰ与IGF-Ⅱ表达及其意义的研究[J].中华肿瘤防治杂志,2008,15(13):976-980. 被引量:11
  • 2文国容,庹必光,刘华庆,李娟,王雪,刘雪梅,于之昊.IGF-Ⅰ和IGF-Ⅱ在人结直肠腺瘤和结直肠癌中的表达及意义[J].贵州医药,2010,34(12):1069-1071. 被引量:8
  • 3潘峰,包迎红,黄瑞燕,李骏白,张镇侠.2001~2005年温州市大肠癌发病率分析[J].中华肿瘤防治杂志,2007,14(17):1286-1287. 被引量:7
  • 4Roddam Alien NE, appleby P, Key TJ, Fer- rucci L, Carter HB, Metter EJ, Chen C, Weiss iNS, Fitzpatrick A, Hsing AW, Lacey JV, Helzlsouer K, Rinaldi S, Riboli E, Kaaks R, Janssen JA, Wildhagen MF, Schr?der FH, Platz EA, Pollak M, Giovannucci E, Schaefer C, Quesenberry CP, Vogelman JH, Severi G, English DR, Giles GG, Stattin P, Hallmans G, Jo- hansson M, Chan JM, Gann P, Oliver SE, Holly JM, Donovan J, Meyer F, Bairati I, Galan P. Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospectivestudies. Ann Intern Med 2008; 149: 461-471, W83-W88 [PMID:18838726 DOI:10.7326/000 3-4819-149-7-200810070-00006].
  • 5Key TJ, Appleby PN, Reeves GK, Roddam AW. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11:530-542 [PMID: 20472501].
  • 6Rinaldi S, Cleveland R, Norat T, Biessy C, Rohrmann S, Linseisen J, Boeing H, Pischon T, Pani- co S, Agnoli C, Palli D, Tumino R, Vineis P, Peeters PH, van Gils CH, Bueno-de-Mesquita BH, Vrieling A, Allen NE, Roddam A, Bingham S, Khaw KT, Manjer J, Borgquist S, Dumeaux V, Torhild Gram I, Lund E, Trichopoulou A, Makrygiannis G, Benetou V, Molina E, Donate Su:rez I, Barricarte Gurrea A, Gonzalez CA, Tormo MJ, Altzibar JM, Olsen A, Tjonneland A, Gronbaek H, Overvad K, Clavel- Chapelon F, Boutron-Ruault MC, Morois S, Slimani N, Boffetta P, Jenab M, Riboli E, Kaaks R. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 2010; 126: 1702-1715 [PMID: 19810099 DOI: 10.1002/ijc.24927].
  • 7Cui H. Loss of imprinting of IGF2 as an epigenetic marker for the risk of human cancer. Dis Markers 2007; 23:105-112 [PMID: 17325430].
  • 8赵凯,范钰,沈琰,李新忠,张小平IGF-Ⅱ、IGF-1R在结肠腺瘤中的表达及其生物学意义陕两医学杂志2009;38:1475.1477.
  • 9Tao Y, Pinzi V, Bourhis J, Deutsch E. Mechanisms of disease: signaling of the insulin-like growth fac- tor 1 receptor pathway-therapeutic perspectives in cancer. Nat Clin Pract Oncol 2007; 4:591-602 [PMID: 17898809 DOI: 10.1038/ncponc0934].
  • 10Jelinic P, Shaw P. Loss of imprinting and cancer. J Pathol 2007; 211:261-268 [PMID: 17177177 DOI: 10.lO02/path.2116].

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部